These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36474125)

  • 1. Application of the long axial field-of-view PET/CT with low-dose [
    Sachpekidis C; Pan L; Kopp-Schneider A; Weru V; Hassel JC; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1158-1167. PubMed ID: 36474125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT.
    Alberts I; Hünermund JN; Prenosil G; Mingels C; Bohn KP; Viscione M; Sari H; Vollnberg B; Shi K; Afshar-Oromieh A; Rominger A
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2395-2404. PubMed ID: 33797596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined whole-body dynamic and static PET/CT with low-dose [
    Sachpekidis C; Pan L; Groezinger M; Strauss DS; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2137-2150. PubMed ID: 38286936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
    Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
    Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image Quality and Quantitative PET Parameters of Low-Dose [
    Calderón E; Schmidt FP; Lan W; Castaneda-Vega S; Brendlin AS; Trautwein NF; Dittmann H; la Fougère C; Kiefer LS
    Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for
    Mohr P; van Sluis J; Providência L; van Snick JH; Lub-de Hooge MN; Willemsen AT; Glaudemans AWJM; Boellaard R; Lammertsma AA; Brouwers AH; Tsoumpas C
    J Nucl Med; 2023 Nov; 64(11):1815-1820. PubMed ID: 37536740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
    Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
    AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
    [No Abstract]   [Full Text] [Related]  

  • 8. Head-to-head intra-individual comparison of total-body 2-[
    Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
    Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the new ultra-high sensitivity mode in a long axial field-of-view PET/CT.
    Mingels C; Weidner S; Sari H; Buesser D; Zeimpekis K; Shi K; Alberts I; Rominger A
    Ann Nucl Med; 2023 May; 37(5):310-315. PubMed ID: 36913094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data.
    van Sluis J; van Snick JH; Brouwers AH; Noordzij W; Dierckx RAJO; Borra RJH; Slart RHJA; Lammertsma AA; Glaudemans AWJM; Boellaard R; Tsoumpas C
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4652-4660. PubMed ID: 35876867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [
    Alberts I; Sachpekidis C; Prenosil G; Viscione M; Bohn KP; Mingels C; Shi K; Ashar-Oromieh A; Rominger A
    Ann Nucl Med; 2021 Apr; 35(4):485-492. PubMed ID: 33550515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of late acquisition [68Ga]Ga-PSMA-11 PET/CT using a long axial field-of-view PET/CT scanner for the diagnosis of recurrent prostate cancer-first clinical experiences.
    Alberts I; Prenosil G; Mingels C; Bohn KP; Viscione M; Sari H; Rominger A; Afshar-Oromieh A
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4456-4462. PubMed ID: 34155538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitigating SUV uncertainties using total body PET imaging.
    Smith CLC; Zwezerijnen GJC; den Hollander ME; Weijland J; Yaqub M; Boellaard R
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1070-1078. PubMed ID: 37953391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of using abbreviated scan protocols with population-based input functions for accurate kinetic modeling of [
    Sari H; Eriksson L; Mingels C; Alberts I; Casey ME; Afshar-Oromieh A; Conti M; Cumming P; Shi K; Rominger A
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):257-265. PubMed ID: 36192468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG imaging with long-axial field-of-view PET/CT in patients with high blood glucose-a matched pair analysis.
    Mingels C; Weissenrieder L; Zeimpekis K; Sari H; Nardo L; Caobelli F; Alberts I; Rominger A; Pyka T
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2036-2046. PubMed ID: 38383743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
    Tan H; Sui X; Yin H; Yu H; Gu Y; Chen S; Hu P; Mao W; Shi H
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
    Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical acceptability of short versus long duration acquisitions for head and neck cancer using long-axial field-of-view PET/CT: a retrospective evaluation.
    Mei R; Pyka T; Sari H; Fanti S; Afshar-Oromieh A; Giger R; Caobelli F; Rominger A; Alberts I
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1436-1443. PubMed ID: 38095670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [
    Mingels C; Spencer BA; Nalbant H; Omidvari N; Rokni M; Rominger A; Sen F; Cherry SR; Badawi RD; Abdelhafez YG; Nardo L
    J Nucl Med; 2024 Jul; 65(7):1101-1106. PubMed ID: 38664017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.